Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Burden | 1 | 2014 | 7 | 0.450 |
Why?
|
| Benzo(a)pyrene | 3 | 2003 | 128 | 0.390 |
Why?
|
| Environmental Exposure | 1 | 2014 | 256 | 0.370 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 201 | 0.370 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2003 | 465 | 0.210 |
Why?
|
| Fetal Death | 1 | 2002 | 18 | 0.190 |
Why?
|
| Carcinogens, Environmental | 1 | 2001 | 35 | 0.170 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2000 | 15 | 0.160 |
Why?
|
| Tennessee | 1 | 2014 | 93 | 0.110 |
Why?
|
| Rats, Inbred F344 | 3 | 2003 | 258 | 0.100 |
Why?
|
| Age Factors | 1 | 2014 | 1154 | 0.090 |
Why?
|
| Infant | 1 | 2014 | 1175 | 0.090 |
Why?
|
| Prevalence | 1 | 2014 | 1612 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2853 | 0.070 |
Why?
|
| Cyclophilin A | 1 | 2007 | 19 | 0.070 |
Why?
|
| Rats | 4 | 2003 | 3735 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 108 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2007 | 74 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 105 | 0.060 |
Why?
|
| Child | 1 | 2014 | 3443 | 0.060 |
Why?
|
| Administration, Inhalation | 2 | 2003 | 92 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 158 | 0.060 |
Why?
|
| Biological Availability | 2 | 2003 | 116 | 0.050 |
Why?
|
| Epididymis | 1 | 2003 | 29 | 0.050 |
Why?
|
| Phenylketonurias | 1 | 2003 | 2 | 0.050 |
Why?
|
| Adolescent | 1 | 2014 | 6081 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2003 | 25 | 0.050 |
Why?
|
| Litter Size | 1 | 2002 | 14 | 0.050 |
Why?
|
| Tyrosine | 1 | 2003 | 120 | 0.050 |
Why?
|
| Carcinogens | 1 | 2003 | 126 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 1124 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2002 | 31 | 0.050 |
Why?
|
| Prolactin | 1 | 2002 | 65 | 0.050 |
Why?
|
| Progesterone | 1 | 2002 | 121 | 0.050 |
Why?
|
| Testis | 1 | 2003 | 207 | 0.050 |
Why?
|
| Maternal Exposure | 1 | 2002 | 57 | 0.050 |
Why?
|
| Male | 4 | 2014 | 23409 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 611 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2002 | 83 | 0.050 |
Why?
|
| Aged | 1 | 2014 | 8214 | 0.040 |
Why?
|
| Female | 4 | 2014 | 24698 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2001 | 14 | 0.040 |
Why?
|
| Middle Aged | 2 | 2014 | 12222 | 0.040 |
Why?
|
| Estrogens | 1 | 2002 | 203 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2001 | 260 | 0.040 |
Why?
|
| Pregnancy | 2 | 2003 | 1772 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 1081 | 0.040 |
Why?
|
| Adult | 2 | 2014 | 13872 | 0.040 |
Why?
|
| Reference Values | 1 | 2000 | 211 | 0.040 |
Why?
|
| Hypertension | 1 | 2006 | 835 | 0.040 |
Why?
|
| Animals | 4 | 2003 | 16992 | 0.030 |
Why?
|
| Humans | 4 | 2014 | 43102 | 0.030 |
Why?
|
| beta Karyopherins | 1 | 2007 | 4 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2007 | 11 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 127 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2007 | 68 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 196 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2007 | 186 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 224 | 0.020 |
Why?
|
| Protein Transport | 1 | 2007 | 296 | 0.020 |
Why?
|
| Dinoprost | 1 | 2006 | 19 | 0.020 |
Why?
|
| Hela Cells | 1 | 2007 | 376 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2007 | 411 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 518 | 0.020 |
Why?
|
| Triglycerides | 1 | 2006 | 147 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2007 | 383 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 436 | 0.010 |
Why?
|
| Zinc | 1 | 2006 | 131 | 0.010 |
Why?
|
| Copper | 1 | 2006 | 134 | 0.010 |
Why?
|
| Cholesterol | 1 | 2006 | 232 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 986 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 389 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 1082 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 1410 | 0.010 |
Why?
|
| Cell Movement | 1 | 2007 | 655 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2003 | 70 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2003 | 61 | 0.010 |
Why?
|
| Sperm Motility | 1 | 2003 | 47 | 0.010 |
Why?
|
| Calibration | 1 | 2003 | 63 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 104 | 0.010 |
Why?
|
| Testosterone | 1 | 2003 | 211 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 1766 | 0.010 |
Why?
|